ROTI®Mark PETIT, 5 mg, verre

N-(4-fluorophenyl)-N-isopropyl-2-((5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl)oxy)acetamide, 98%, 1g

1,5-Dibromopentane>98.0%(GC)25g

7-Bromobenzo[d]oxazole, 95.0%, 250mg

Ethyl 4-aminopyrimidine-2-carboxylate, 95.0%, 1g

DBCO-NHS ester, 99.53%, 100mg

2-Methyl-1-pentene>98.0%(GC)100mL

Hydroxyde de tétrabutylammonium, 40 % dans l'eau, 25 ml, conditionnement en verre

(5-Bromo-2-methylpyridin-4-yl)methanol, 97%, 250mg

Ethyl 5-hydroxy-2-iodobenzoate, 95.0%, 250mg

tert-butyl N-[(tert-butoxy)carbonyl]-N-{3H-imidazo[4,5-c]pyridin-4-yl}carbamate, 97%, 100mg

tert-Butyl 6-Chloropyridin-2-ylcarbamate, 97.0%, 10g

7-benzyloxy-4-chloro-6-methoxyquinazoline, 95.0%, 25g